PPA
ADMA icon

Parametric Portfolio Associates’s ADMA Biologics ADMA Stock Holding History

Parametric Portfolio Associates’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-147,855
Closed -$237K – 3601
2021
Q2 		$237K Buy
147,855
+113,797
+334% +$200K ﹤0.01% 3346
2021
Q1 		$60K Buy
34,058
+14,931
+78% +$34.2K ﹤0.01% 4012
2020
Q4 		$37K Buy
+19,127
New +$40.2K ﹤0.01% 3960
2020
Q3 		– Sell
-12,697
Closed -$37K – 3924
2020
Q2 		$37K Buy
12,697
+1,449
+13% +$4.16K ﹤0.01% 3880
2020
Q1 		$32K Sell
11,248
-7,905
-41% -$27.3K ﹤0.01% 3870
2019
Q4 		$77K Buy
19,153
+3,902
+26% +$17K ﹤0.01% 3887
2019
Q3 		$68K Buy
15,251
+2,707
+22% +$11.3K ﹤0.01% 3878
2019
Q2 		$49K Buy
+12,544
New +$55.4K ﹤0.01% 3910

Other funds holding ADMA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parametric Portfolio Associates's ADMA Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of ADMA Biologics (ADMA) in Q3 2021, closing a stake of 147,855 shares — an estimated $237K sold.

Parametric Portfolio Associates first reported a position in ADMA in Q2 2019 and held it in 8 quarters. The position peaked at $237K in Q2 2021. 72 funds tracked by Wall St. Rank hold ADMA as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining ADMA Biologics position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 147,855 ADMA Biologics shares in Q3 2021, an estimated $237K.
  • Parametric Portfolio Associates first reported a position in ADMA Biologics in Q2 2019 and held it in 8 quarters.
  • Parametric Portfolio Associates's ADMA Biologics position peaked at $237K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.